Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
- 1 April 1992
- journal article
- Published by Elsevier in The Lancet
- Vol. 339 (8799), 943-946
- https://doi.org/10.1016/0140-6736(92)91528-g
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.Environmental Health Perspectives, 1993
- Nonviral Risk Factors for Hepatocellular Carcinoma in a Low-Risk Population, the Non-Asians of Los Angeles County, CaliforniaJNCI Journal of the National Cancer Institute, 1991
- Aflatoxin exposure, hepatitis b virus infection and liver cancer in swazilandInternational Journal of Cancer, 1987
- Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography.Proceedings of the National Academy of Sciences, 1985
- High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays.Proceedings of the National Academy of Sciences, 1984
- A Case-Control Dietary Study of Primary Liver Cancer Risk from Aflatoxin Exposure*International Journal of Epidemiology, 1982
- Association between aflatoxin content of food and hepatoma frequency in UgandaCancer, 1971